Ethanol-induced inhibition of fetal hypothalamic-pituitary-adrenal axis due to prenatal overexposure to maternal glucocorticoid in mice

Experimental and Toxicologic Pathology

Volumn 63, Issue 7-8, 2011, Pages 607-611

  Liang, Gai ^a   Chen, Man ^a   Pan, Xiao liang ^a   Zheng, Jiang ^b   Wang, Hui ^a  

^a WUHAN UNIVERSITY   (China)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Corticosterone 11 hydroxysteroid dehydrogenase type 2; Hypothalamus pituitary adrenal; Intrauterine growth retardation; P450scc; Prenatal ethanol exposure; Steroidogenic acute regulatory protein

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 2; ALCOHOL; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CORTICOSTERONE; STEROIDOGENIC ACUTE REGULATORY PROTEIN;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS; FETUS WEIGHT; GENE EXPRESSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAUTERINE GROWTH RETARDATION; MATERNAL BLOOD; MOUSE; NONHUMAN; PLACENTA; PLACENTA WEIGHT; PRENATAL DRUG EXPOSURE; REAL TIME POLYMERASE CHAIN REACTION; WEIGHT GAIN;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ANIMALS; BODY WEIGHT; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME; CORTICOSTERONE; ETHANOL; FEMALE; FETAL DEVELOPMENT; FETAL GROWTH RETARDATION; FETAL WEIGHT; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MATERNAL EXPOSURE; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED STRAINS; PITUITARY-ADRENAL SYSTEM; PLACENTA; PREGNANCY; RNA, MESSENGER; SPECIFIC PATHOGEN-FREE ORGANISMS;

MUS;

EID: 80053237831     PISSN: 09402993     EISSN: 16181433     Source Type: Journal    
DOI: 10.1016/j.etp.2010.04.015     Document Type: Article

References (33)

1. Barbazanges A., Piazza P.V., Le Moal M., Maccari S. Maternal glucocorticoid secretion mediates long-term effects of prenatal stress. J Neurosci 1996, 16(12):3943-3949.
2. Bartha J.L., Romero-Carmona R., Comino-Delgado R. Inflammatory cytokines in intrauterine growth retardation. Acta Obstet Gynecol Scand 2003, 82(12):1099-1102.
3. Bryan S.M., Hindmarsh P.C. Normal and abnormal fetal growth. Horm Res 2006, 65(Suppl. 3):19-27.
4. Campbell A.L., Murphy B.E. The maternal-fetal cortisol gradient during pregnancy and at delivery. J Clin Endocrinol Metab 1977, 45(3):435-440.
5. Chatelain P. Children born with intra-uterone growth retardation (IUGR) or small for gestational age (SGA): long term growth and metabolic consequences. Endocr Regul 2000, 34(1):33-36.
6. Chen M., Wang T., Liao Z.X., Pan X.L., Feng Y.H., Wang H. Nicotine-induced prenatal overexposure to maternal glucocorticoid and intrauterine growth retardation in rat. Exp Toxicol Pathol 2007, 59(3-4):245-251.
7. Dalle M., Delost P. Plasma and adrenal cortisol concentrations in foetal, newborn and mother guinea-pigs during the perinatal period. J Endocrinol 1976, 70(2):207-214.
8. Desai M., Crowther N.J., Lucas A., Hales C.N. Organ-selective growth in the offspring of protein-restricted mothers. Br J Nutr 1996, 76(4):591-603.
9. Eleftheriades M., Creatsas G., Nicolaides K. Fetal growth restriction and postnatal development. Ann N Y Acad Sci 2006, 1092:319-330.
10. Fowden A.L., Forhead A.J. Endocrine mechanisms of intrauterine programming. Reproduction 2004, 127:515-526.
11. Fowden A.L., Giussani D.A., Forhead A.J. Endocrine and metabolic programming during intrauterine development. Early Hum Dev 2005, 81:723-734.
12. Herman J.P., Cullinan W.E. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 1997, 20(2):78-84.
13. Herman J.P., Ostrander M.M., Mueller N.K., Figueiredo H. Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29(8):1201-1213.
14. Iqbal U., Brien J.F., Kapoor A., Matthews S.G., Reynolds J.N. Chronic prenatal ethanol exposure increases glucocorticoid-induced glutamate release in the hippocampus of the near-term foetal guinea pig. J Neuroendocrinol 2006, 18(11):826-834.
15. Jones K.L., Smith D.W. Recognition of the fetal alcohol syndrome in early infancy. Lancet 1973, 302(7836):999-1001.
16. Kossintseva I., Wong S., Johnstone E., Guilbert L., Olson D.M., Mitchell B.F. Proinflammatory cytokines inhibit human placental 11beta-hydroxysteroid dehydrogenase type 2 activity through Ca2+ and cAMP pathways. Am J Physiol Endocrinol Metab 2006, 290:282-288.
17. Lappas M., Permezel M., Rice G.E. Release of proinflammatory cytokines and 8-isoprostane from placenta, adipose tissue, and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus. J Clin Endocrinol Metab 2004, 89(11):5627-5633.
18. Liang G., Xu D., He W.W., Zhang B.J., Wang H. Toxic effect and neuroendocrine mechanism of caffeine on fatal development in pregnant rats. Drug Metab Rev 2009, 41(Suppl. 2):48-49.
19. Mesiano S., Jaffe R.B. Developmental and functional biology of the primate fetal adrenal cortex. Endocr Rev 1997, 18:378-403.
20. McNeil C.J., Nwagwu M.O., Finch A.M., Page K.R., Thain A., McArdle H.J., et al. Glucocorticoid exposure and tissue gene expression of 11beta HSD-1, 11beta HSD-2, and glucocorticoid receptor in a porcine model of differential fetal growth. Reproduction 2007, 133(3):653-661.
21. Myatt L., Kossenjans W., Sahay R., Eis A., Brockman D. Oxidative stress causes vascular dysfunction in the placenta. J Matern Fetal Med 2000, 9(1):79-82.
22. Ozanne S.E., Hales C.N. Early programming of glucose-insulin metabolism. Trends Endocrinol Metab 2002, 13(9):368-373.
23. Pezzi V., Mathis J.M., Rainey W.E., Carr B.R. Profiling transcript levels for steroidogenic enzymes in fetal tissues. J Steroid Biochem Mol Biol 2003, 87:181-189.
24. Reagan-Shaw S., Nihal M., Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008, 22(3):659-661.
25. Seckl J.R. Glucocorticoids, feto-placental 11 beta-hydroxysteroid dehydrogenase type 2, and the early life origins of adult disease. Steroids 1997, 62:89-94.
26. Stallmach T., Hebisch G., Joller-Jemelka H.I., Orban P., Schwaller J., Engelmann M. Cytokine production and visualized effects in the feto-maternal unit. Quantitative and topographic data on cytokines during intrauterine disease. Lab Invest 1995, 73(3):384-392.
27. Symonds M.E., Pearce S., Bispham J., Gardner D.S., Stephenson T. Timing of nutrient restriction and programming of fetal adipose tissue development. Proc Nutr Soc 2004, 63(3):397-403.
28. Tagawa N., Yuda R., Kubota S., Wakabayashi M., Yamaguchi Y., Kiyonaga D., et al. 17Beta-estradiol inhibits 11beta-hydroxysteroid dehydrogenase type 1 activity in rodent adipocytes. J Endocrinol 2009, 202(1):131-139.
29. Valsamakis G., Kanaka-Gantenbein C., Malamitsi-Puchner A., Mastorakos G. Causes of intrauterine growth restriction and the postnatal development of the metabolic syndrome. Ann N Y Acad Sci 2006, 1092:138-147.
30. Wadhwa P.D., Dunkel-Schetter C., Chicz-DeMet A., Porto M., Sandman C.A. Prenatal psychosocial factors and the neuroendocrine axis in human pregnancy. Psychosom Med 1996, 58(5):432-446.
31. Weinberg J., Sliwowska J.H., Lan N., Hellemans K.G. Prenatal alcohol exposure: foetal programming, the hypothalamic-pituitary-adrenal axis and sex differences in outcome. J Neuroendocrinol 2008, 20(4):470-488.
32. Weinstock M. The potential influence of maternal stress hormones on development and mental health of the offspring. Brain Behav Immun 2005, 19(4):296-308.
33. Zimatkin S.M., Pronko S.P., Vasiliou V., Gonzalez F.J., Deitrich R.A. Enzymatic mechanisms of ethanol oxidation in the brain. Alcohol Clin Exp Res 2006, 30(9):1500-1505.